WOAG
WITHDRAWAL OF ATTORNEY GRANTED
01/02/2026
Back to search
Official data from USPTO
SINGLERON
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
SINGLERON
ST13
US500000088277348Class
1, 42
Filing
88277348
Registration
5993909
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
30
Latest update
04/03/2026
Trademark type
Word
Nice classes
1, 42
Filing date
01/25/2019
Registration date
02/25/2020
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
02/25/2020
Last transaction
04/03/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use, Foreign priority
Drawing code
4
Owner type
99
Owner location
JIANGSU, CN
Examiner
GARCIA, CLAUDIA
Law office
M20
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
SINGLERON (NANJING) BIOTECHNOLOGIES CO., LTD.
Singleron Biotechnologies Ltd.
Representatives
SINGLERON (NANJING) BIOTECHNOLOGIES CO., LTD.
Technical classification
Nice Classes
Class 1Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Nucleic acid sequencing programs in the nature of single cell analysis other than for medical use; nucleic acids for laboratory use; nucleic acids for scientific purposes; nucleic acid for use in nucleic acid amplification processes other than for medical use; nucleic acid amplification reagents other than for medical use; polymers for use in the analysis of nucleic acids; nucleic recombinant acids for laboratory use
Class 42
Drug discovery services; development of pharmaceutical preparations and medicines; research and development in the field of biotechnology; research and development in the pharmaceutical; clinical research in the field of single cell analysis; biotechnology testing in the field of single cell analysis
Publications
History of USPTO decisions and trademark events.
30 publications found
WOAR
TEAS WITHDRAWAL OF ATTORNEY RECEIVED
01/02/2026
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
01/02/2026
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
01/02/2026
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
01/02/2026
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
01/02/2026
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
01/02/2026
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
02/25/2025
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
07/06/2022
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
06/08/2022
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
06/08/2022
EWAF
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
06/08/2022
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
06/08/2022
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
06/08/2022
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
06/08/2022
R.PR
REGISTERED-PRINCIPAL REGISTER
02/25/2020
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
12/10/2019
PUBO
PUBLISHED FOR OPPOSITION
12/10/2019
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
11/20/2019
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
11/04/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
10/17/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
10/17/2019
ALIE
ASSIGNED TO LIE
10/14/2019
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
10/08/2019
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
04/08/2019
GNRT
NON-FINAL ACTION E-MAILED
04/08/2019
CNRT
NON-FINAL ACTION WRITTEN
04/08/2019
DOCK
ASSIGNED TO EXAMINER
04/08/2019
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
02/19/2019
NWAP
NEW APPLICATION ENTERED
01/29/2019
Continuous trademark protection
Get notified about every new filing that threatens SINGLERON or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.